|
|
|
Insider
Information: |
Mast Erle T |
Relationship: |
Director |
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
142,283 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,034 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
142,283 |
|
|
Total
Value |
$2,034 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
EVP, CFO |
2008-03-07 |
0 |
|
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2008-12-31 |
0 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
Director |
2022-03-07 |
0 |
2010-12-10 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
Executive VP and CFO |
2015-11-02 |
135,583 |
2011-11-21 |
0 |
Premium* |
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2014-03-14 |
0 |
Premium* |
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
Director |
2017-08-01 |
6,700 |
2017-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
WTKND |
Welltek Incorporated |
Chief Financial OfficerOfficer |
|
2003-11-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,784 |
|
- |
|
WTKND |
Welltek Incorporated |
Sr. Vice President, Chief Fina |
|
2007-08-06 |
144 |
NP |
$0.00 |
$2,100,000 |
/ |
50,000 |
0 |
|
- |
|
WTKND |
Welltek Incorporated |
EVP, CFO |
|
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,109) |
0 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, CFO |
|
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(816) |
73,109 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2008-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
543 |
543 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,543 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,042 |
54,448 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,648 |
65,096 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,534 |
66,630 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
|
2011-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,110 |
213,260 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
69,808 |
91,438 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
66,842 |
158,280 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
57,414 |
215,694 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,820 |
34,781 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2013-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(39,162) |
0 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,400 |
7,700 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-08-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(300) |
7,400 |
0 |
- |
|
RCPT |
Receptos, Inc. |
Director |
|
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,400) |
0 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
Director |
|
2022-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,027) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2011-10-03 |
4 |
AS |
$0.85 |
$4,259 |
D/D |
(5,000) |
21,630 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2011-08-15 |
4 |
AS |
$1.11 |
$5,561 |
D/D |
(5,000) |
26,630 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
Director |
|
2012-12-11 |
4 |
B |
$1.15 |
$11,500 |
D/D |
10,000 |
16,721 |
2.39 |
- |
|
ZGNX |
Zogenix, Inc. |
Director |
|
2015-03-13 |
4 |
A |
$1.31 |
$9,825 |
D/D |
7,500 |
24,221 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, CFO |
|
2007-08-06 |
4 |
OE |
$1.60 |
$90,000 |
D/D |
50,000 |
58,284 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, CFO |
|
2008-03-03 |
4 |
OE |
$1.60 |
$100,000 |
D/D |
62,500 |
71,300 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|